Royalty Pharma Sub-Manager, LLC 13F Holdings & Recent Stock Buys (Q2 2026)

Royalty Pharma Sub-Manager, LLC's disclosed holdings carry a Herfindahl concentration index of 0.265 — mathematically equivalent to about 4 equally-sized positions, close to its 4 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.

Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.28), suggesting a disciplined, rules-based approach to how much capital goes into each idea.

Recent activity leans toward initiating meaningfully larger new positions than it adds to existing ones (a 22.4 percentage-point tilt) — a pattern consistent with a more contrarian, new-idea-driven approach.

Sector classification currently covers about 35% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.